Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
VF Vasconcellos, GN Marta… - Cochrane Database …, 2020 - cochranelibrary.com
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
VF Vasconcellos, GN Marta… - The Cochrane …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
VF Vasconcellos, GN Marta, EM da Silva… - The Cochrane …, 2020 - europepmc.org
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
[HTML][HTML] Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
VF Vasconcellos, GN Marta, EMK da Silva… - The Cochrane …, 2020 - ncbi.nlm.nih.gov
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
[引用][C] Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
VF VASCONCELLOS, GN MARTA… - Cochrane Database …, 2020 - observatorio.fm.usp.br
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
VF Vasconcellos, GN Marta… - Cochrane Database …, 1996 - cochranelibrary.com
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
[PDF][PDF] Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
VF Vasconcellos, GN Marta, EMK da Silva… - status and date: New …, 2020 - researchgate.net
Background Lung cancer is the most commonly diagnosed cancer and the leading cause of
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …
cancer death in both sexes worldwide. Approximately 50% of those diagnosed with lung …